Independent predictors of stroke in patients with atrial fibrillation: a systematic review
- PMID: 17679673
- DOI: 10.1212/01.wnl.0000267275.68538.8d
Independent predictors of stroke in patients with atrial fibrillation: a systematic review
Abstract
Background: Absolute stroke rates vary widely among patients with nonvalvular atrial fibrillation. To balance the benefits and risks of chronic antithrombotic prophylaxis, it is important to estimate the absolute risk of stroke for individual patients.
Methods: Systematic review of studies using multivariate regression techniques to identify independent risk factors for stroke in patients with atrial fibrillation was conducted, and reports of absolute stroke rates in subgroups of patients with these risk factors collected. A summary estimate of the relative risk associated with each independent risk factor was calculated using maximum likelihood methods.
Results: Seven studies (including six entirely independent cohorts) were identified. Prior stroke/TIA (relative risk 2.5, 95% CI 1.8 to 3.5), increasing age (relative risk 1.5 per decade, 95% CI 1.3 to 1.7), a history of hypertension (relative risk 2.0, 95% CI 1.6 to 2.5), and diabetes mellitus (relative risk 1.7, 95% CI 1.4 to 2.0) were the strongest, most consistent independent risk factors. Observed absolute stroke rates for nonanticoagulated patients with single independent risk factors were in the range of 6 to 9% per year for prior stroke/TIA, 1.5 to 3% per year for history of hypertension, 1.5 to 3% per year for age >75, and 2.0 to 3.5% per year for diabetes. Female sex was inconsistently associated with stroke risk, whereas the evidence was inconclusive that either heart failure or coronary artery disease is independently predictive of stroke.
Conclusions: Four clinical features (prior stroke/TIA, advancing age, hypertension, diabetes) are consistent independent risk factors for stroke in atrial fibrillation patients. Prior stroke/TIA is the most powerful risk factor and reliably confers a high stroke risk (>5% per year, averaging 10% per year). Absolute stroke rates associated with other individual risk factors are difficult to precisely estimate from available data.
Similar articles
-
Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.J Cardiovasc Electrophysiol. 2012 Jul;23(7):708-13. doi: 10.1111/j.1540-8167.2011.02257.x. Epub 2012 Jan 23. J Cardiovasc Electrophysiol. 2012. PMID: 22268375
-
Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system.J Neurol Sci. 2011 Feb 15;301(1-2):27-30. doi: 10.1016/j.jns.2010.11.011. Epub 2010 Dec 4. J Neurol Sci. 2011. PMID: 21130468
-
Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.Angiology. 2015 May;66(5):464-71. doi: 10.1177/0003319714536980. Epub 2014 Jun 5. Angiology. 2015. PMID: 24904179
-
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007. Can J Cardiol. 2011. PMID: 21329865
-
[Atrial fibrillation and thromboembolic events prevention. State of the art].Minerva Cardioangiol. 2001 Feb;49(1):1-13. Minerva Cardioangiol. 2001. PMID: 11279381 Review. Italian.
Cited by
-
A Program to Optimize the Detection of Paroxysmal Atrial Fibrillation: The RITMO Study.Arq Bras Cardiol. 2024 Sep 23;121(9):e20240235. doi: 10.36660/abc.20240235. eCollection 2024. Arq Bras Cardiol. 2024. PMID: 39352184 Free PMC article. English, Portuguese.
-
Early statin use is associated with improved survival and cardiovascular outcomes in patients with atrial fibrillation and recent ischaemic stroke: A propensity-matched analysis of a global federated health database.Eur Stroke J. 2024 Sep 10:23969873241274213. doi: 10.1177/23969873241274213. Online ahead of print. Eur Stroke J. 2024. PMID: 39254367 Free PMC article.
-
Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohort.Lancet Reg Health Eur. 2024 Jun 10;43:100967. doi: 10.1016/j.lanepe.2024.100967. eCollection 2024 Aug. Lancet Reg Health Eur. 2024. PMID: 39171253 Free PMC article.
-
Risk of stroke in male and female patients with atrial fibrillation in a nationwide cohort.Nat Commun. 2024 Aug 7;15(1):6728. doi: 10.1038/s41467-024-51193-0. Nat Commun. 2024. PMID: 39112527 Free PMC article.
-
Screening for atrial fibrillation: the role of CHA2DS2-VASc and atrial fibrillation burden.Eur Heart J Suppl. 2024 Jul 31;26(Suppl 4):iv41-iv49. doi: 10.1093/eurheartjsupp/suae078. eCollection 2024 Jul. Eur Heart J Suppl. 2024. PMID: 39099574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical